sglt2 inhibition: a novel treatment strategy for type 2 diabetes mellitus
TRANSCRIPT
![Page 1: SGLT2 INHIBITION: A NOVEL TREATMENT STRATEGY FOR TYPE 2 DIABETES MELLITUS](https://reader033.vdocuments.site/reader033/viewer/2022051019/5697bfb51a28abf838c9ddf5/html5/thumbnails/1.jpg)
SGLT2 INHIBITION:
A NOVEL TREATMENT
STRATEGY FOR TYPE 2 DIABETES
MELLITUS
![Page 2: SGLT2 INHIBITION: A NOVEL TREATMENT STRATEGY FOR TYPE 2 DIABETES MELLITUS](https://reader033.vdocuments.site/reader033/viewer/2022051019/5697bfb51a28abf838c9ddf5/html5/thumbnails/2.jpg)
SGLT2 INHIBITOR: WHERE DO THEY FIT IN THE TREATMENT ALGORITHM
●Monotherapy●Add-on to: MET, SU, PIO●Add-on to oral combo therapy●Double/Triple combo therapy ●Add-on to insulin in T2DM●Add-on to insulin in T1DM● IGT/IFG●A1c > 10.0%
![Page 3: SGLT2 INHIBITION: A NOVEL TREATMENT STRATEGY FOR TYPE 2 DIABETES MELLITUS](https://reader033.vdocuments.site/reader033/viewer/2022051019/5697bfb51a28abf838c9ddf5/html5/thumbnails/3.jpg)
SGLT 2 INHIBITION: MEETING UNMETNEEDS IN DIABETES CARE
Corrects a Novel Pathophysiologic
Defect
ReducesHbA1c
Promotes Weight Loss
ComplementsAction of Other
AntidiabeticAgents
Reduces Blood
Pressure NoHypoglycemia
Improves GlycemicControl
and CVRFs
Reversal ofGlucotoxicity
![Page 4: SGLT2 INHIBITION: A NOVEL TREATMENT STRATEGY FOR TYPE 2 DIABETES MELLITUS](https://reader033.vdocuments.site/reader033/viewer/2022051019/5697bfb51a28abf838c9ddf5/html5/thumbnails/4.jpg)
GLP1TZDs
GLP1
GLP1HYPERGLYCEMI
AHYPERGLYCEMI
A
DecreasedIncretin Effect
DecreasedIncretin Effect
Decreased InsulinSecretion
IncreasedHGP
Islet– a cell
IncreasedGlucagonSecretion
OMINOUS OCTET
IncreasedLipolysis
IncreasedGlucose
Reabsorption
NeurotransmitterDysfunction
TZDs
GLP1
TZDsGLP1
TZDsMETGLP1
Decreased Glucose
Uptake
![Page 5: SGLT2 INHIBITION: A NOVEL TREATMENT STRATEGY FOR TYPE 2 DIABETES MELLITUS](https://reader033.vdocuments.site/reader033/viewer/2022051019/5697bfb51a28abf838c9ddf5/html5/thumbnails/5.jpg)
![Page 6: SGLT2 INHIBITION: A NOVEL TREATMENT STRATEGY FOR TYPE 2 DIABETES MELLITUS](https://reader033.vdocuments.site/reader033/viewer/2022051019/5697bfb51a28abf838c9ddf5/html5/thumbnails/6.jpg)
![Page 7: SGLT2 INHIBITION: A NOVEL TREATMENT STRATEGY FOR TYPE 2 DIABETES MELLITUS](https://reader033.vdocuments.site/reader033/viewer/2022051019/5697bfb51a28abf838c9ddf5/html5/thumbnails/7.jpg)
EXENATIDEAND NO HYPO USED WITH NO SU
EXENATIDE
Always try GLP-1 RA before Insulin
![Page 8: SGLT2 INHIBITION: A NOVEL TREATMENT STRATEGY FOR TYPE 2 DIABETES MELLITUS](https://reader033.vdocuments.site/reader033/viewer/2022051019/5697bfb51a28abf838c9ddf5/html5/thumbnails/8.jpg)
PATHOPHYSIOLOGIC-BASED (DEFRONZO) ALGORITHM
Lifestyle +TRIPLE COMBINATION:
PIO + Metformin + GLP-1 Analogue
HbA1c < 6.0%
![Page 9: SGLT2 INHIBITION: A NOVEL TREATMENT STRATEGY FOR TYPE 2 DIABETES MELLITUS](https://reader033.vdocuments.site/reader033/viewer/2022051019/5697bfb51a28abf838c9ddf5/html5/thumbnails/9.jpg)
Insulin use ben/risk
![Page 10: SGLT2 INHIBITION: A NOVEL TREATMENT STRATEGY FOR TYPE 2 DIABETES MELLITUS](https://reader033.vdocuments.site/reader033/viewer/2022051019/5697bfb51a28abf838c9ddf5/html5/thumbnails/10.jpg)
![Page 11: SGLT2 INHIBITION: A NOVEL TREATMENT STRATEGY FOR TYPE 2 DIABETES MELLITUS](https://reader033.vdocuments.site/reader033/viewer/2022051019/5697bfb51a28abf838c9ddf5/html5/thumbnails/11.jpg)
![Page 12: SGLT2 INHIBITION: A NOVEL TREATMENT STRATEGY FOR TYPE 2 DIABETES MELLITUS](https://reader033.vdocuments.site/reader033/viewer/2022051019/5697bfb51a28abf838c9ddf5/html5/thumbnails/12.jpg)